Retrobulbar haemodynamic effects of the latanoprost/timolol and the dorzolamide/timolol fixed combinations in newly diagnosed glaucoma patients

International Journal of Clinical Practice

Volumn 61, Issue 5, 2007, Pages 815-825

  Martinez, A ^a,b   Sanchez, M ^a  

^a Instituto Gallego de Oftalmologia   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; LATANOPROST PLUS TIMOLOL MALEATE; TIMOLOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERY RESISTANCE; ARTICLE; CILIARY ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; EYE BLOOD FLOW; FEMALE; HEMODYNAMICS; HUMAN; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; OPHTHALMIC ARTERY; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; CILIARY ARTERIES; CROSS-OVER STUDIES; DRUG COMBINATIONS; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMIC ARTERY; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC; SULFONAMIDES; THIOPHENES; TIMOLOL;

EID: 34247127350     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01126.x     Document Type: Article

References (53)

1. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol, 2000; 130: 429-40.
2. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998; 126: 487-97.
3. Mao LK, Stewart WC, Shields MB. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 1991; 111: 51-5.
4. Galassi F, Sodi A, Ucci F et al. Ocular hemodynamics and glaucoma prognosis: a color Doppler imaging study. Arch Ophthalmol 2003; 121: 1711-5.
5. Satilmis M, Orgul S, Doubler B, Flammer J. Rate of progression of glaucoma correlates with retrobulbar circulation and intraocular pressure. Am J Ophthalmol 2003; 135: 664-9.
6. Martinez A, Sanchez M. Predictive value of color Doppler imaging in a prospective study of visual field progression in primary open-angle glaucoma. Acta Ophthalmol Scand 2005; 83: 716-23.
7. Diestelhorst M, Almegard B. Comparison of two fixed combinations of latanoprost and timolol in open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 1998; 236: 577-81.
8. Larsson LI. Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension. J Glaucoma 2001; 10: 109-14.
9. Larsson LI. The effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension. Acta Ophthalmol Scand 2001; 79: 125-8.
10. Higginbotham EJ, Feldman R, Stiles M, Dubiner H; Fixed Combination Investigative Group. Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial. Arch Ophthalmol 2002; 120: 915-22.
11. Pfeiffer N, European Latanoprost Fixed Combination Study Group. A comparison of the fixed combination of latanoprost and timolol with its individual components. Graefes Arch Clin Exp Ophthalmol 2002; 240: 893-9.
12. Konstas AG, Papapanos P, Tersis I, Houliara D, Stewart WC. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination. Ophthalmology 2003; 110: 1357-60.
13. Diestelhorst M, Larsson LI, European Latanoprost Fixed Combination Study Group. A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension. Br J Ophthalmol 2004; 88: 199-203.
14. Shin DH, Feldman RM, Sheu WP, Fixed Combination Latanoprost/ Timolol Study Group. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure. Ophthalmology 2004; 111: 276-82.
15. Diestelhorst M, Larsson LI, European-Canadian Latanoprost Fixed Combination Study Group. A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components. Ophthalmology 2006; 113: 70-6.
16. Strohmaier K, Snyder E, DuBiner H, Adamsons I. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group. Ophthalmology 1998; 105: 1936-44.
17. Boyle JE, Ghosh K, Gieser DK, Adamsons IA. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group. Ophthalmology 1998; 105: 1945-51.
18. Clineschmidt CM, Williams RD, Snyder E, Adamsons IA. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group. Ophthalmology 1998; 105: 1952-9.
19. Hutzelmann J, Owens S, Shedden A, Adamsons I, Vargas E. Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. International Clinical Equivalence Study Group. Br J Ophthalmol 1998; 82: 1249-53.
20. Strohmaier K, Snyder E, DuBiner H, Adamsons I. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Ophthalmology 1999; 106 (12 Suppl.): 1-9.
21. Boyle JE, Ghosh K, Gieser DK, Adamsons IA. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Ophthalmology 1999; 106 (12 Suppl.): 10-6.
22. Clineschmidt CM, Williams RD, Snyder E, Adamsons IA. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Ophthalmology 1999; 106 (12 Suppl.): 17-24.
23. Henderer JD, Wilson RP, Moster MR et al. Timolol/dorzolamide combination therapy as initial treatment for intraocular pressure over 30 mmHg. J Glaucoma 2005; 14: 267-70.
24. Harris A, Spaeth GL, Sergott RC, Katz LJ, Cantor LB, Martin BJ. Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucoma. Am J Ophthalmol 1995; 120: 168-75.
25. Nicolela MT, Buckley AR, Walman BE, Drance SM. A comparative study of the effects of timolol and latanoprost on blood flow velocities of the retrobulbar vessels. Am J Ophthalmol 1996; 122: 784-9.
26. Altan-Yaycioglu R, Turder G, Akdol S, Izgi B. The effects of beta-blockers on ocular blood flow in patients with primary open-angle glaucoma: a color Doppler imaging study. Eur J Ophthalmol 2001; 11: 37-46.
27. Bergstrand IC, Heijl A, Wollmer P, Hansen F, Harris A. Timolol increased retrobulbar flow velocities in untreated glaucoma eyes but not in ocular hypertension. Acta Ophthalmol Scand 2001; 79: 455-61.
28. Serle JB, Podos SM, Kitazawa Y, Wang RF. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes. Jpn J Ophthalmol 1998; 42: 95-100.
29. Akarsu C, Bilgili YK, Taner P, Unal B, Ergin A. Short-term effect of latanoprost on ocular circulation in ocular hypertension. Clin Exp Ophthalmol 2004; 32: 373-7.
30. Martinez A, Sanchez M. A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients. Curr Med Res Opin 2006; 22: 67-73.
31. Erkin EF, Tarhan S, Kayikcioglu OR, Deveci H, Guler C, Goktan C. Effects of betaxolol and latanoprost on ocular blood flow and visual fields in patients with primary open-angle glaucoma. Eur J Ophthalmol 2004; 14: 211-9.
32. Haseguwa T, Hara K, Hara S. Binding of dorzolamide and its metabolites; N-deethylated dorzolamide, to human erythrocytes in vitro. Drug Metab Dispos 1994; 22: 377-82.
33. Martinez A, Gonzalez F, Capeans C, Perez R, Sanchez-Salorio M. Dorzolamide effect on the ocular blood flow. Invest Ophthalmol Vis Sci 1999; 40: 1270-5.
34. Avunduk AM, Sari A, Akyol N et al. The one-month effects of topical betaxolol, dorzolamide and apraclonidine on ocular blood flow velocities in patients with newly diagnosed primary open-angle glaucoma. Ophthalmologica 2001; 215: 361-5.
35. Galassi F, Sodi A, Renieri G et al. Effects of timolol and dorzolamide on retrobulbar hemodynamics in patients with newly diagnosed primary open-angle glaucoma. Ophthalmologica 2002; 216: 123-8.
36. Harris A, Jonescu-Cuypers CP, Kagemann L et al. Effect of dorzolamide timolol combination versus timolol 0.5% on ocular blood flow in patients with primary open-angle glaucoma. Am J Ophthalmol 2001; 132: 490-5.
37. Pourcelot L. Indications de l'ultrasonographie Doppler dans l'etude des vaisseaux peripheriques. Rev Prat 1975; 25: 4671-80.
38. Asman P, Heijl A. Glaucoma Hemifield Test. Automated visual field evaluation. Arch Ophthalmol 1992; 110: 812-9.
39. Hodapp E, Parrish RK II, Anderson DR. Clinical Decisions in Glaucoma. St Louis, MO: Mosby, 1993.
40. Lalle PA. Evaluation of automated perimetry. In: Litwak A, ed. Glaucoma Handbook. Boston: Butterworth-Heinemann, 2001: 97-167.
41. SPSS Inc. SPSS (Computer Program). Version 12.0. Chicago, IL: SPSS Inc., 2004.
42. Astin M. Effects of prostaglandin E2, F2 alpha and latanoprost acid on isolated ocular blood vessels in vitro. J Ocul Ophthalmol 1998; 14: 119-28.
43. Brogiolo G, Flammer J, Haefliger IO. Latanoprost is a vasoconstrictor in isolated porcine ciliary arteries. Klin Monastsbl Augenheilkd 2001; 218: 373-5.
44. Ishii K, Araie M. Effect of topical latanoprost-timolol combined therapy on retinal blood flow and circulation of optic nerve head tissue cynomolgus monkeys. Jpn J Ophthalmol 2000; 44: 227-34.
45. Zeitz O, Matthiessen ET, Reuss J et al. Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide. BMC Ophthalmol 2005; 5: 6. doi:10.1186/1471-2415/5/6.
46. Vetrugno M, Cantatore F, Gigante G, Cardia L. Latanoprost 0.0005% in POAG: effects on IOP and ocular blood flow. Acta Ophthalmol Scand 1998; 227 (Suppl.): 40-1.
47. McKibbin M, Menage MJ. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. Eye 1999; 13: 31-4.
48. Janulevicienë I, Harris A, Kagemann L et al. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients. Acta Ophthalmol Scand 2004; 82: 730-7.
49. Van Buskirk EM, Bacon DR, Fahrenbach WH. Ciliary vasoconstriction after topical adrenergic drugs. Am J Ophthalmol 1990; 109: 511-7.
50. Vysniauskine I, Allemann R, Flammer J, Haefliger IO. Vasoactive response of U46619, PGF 2 (alpha), latanoprost, and travoprost in isolated porcine ciliary arteries. Invest Ophthalmol Vis Sci 2006; 47: 295-8.
51. Alm A, Bill A. The oxygen supply to the retina, II: effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats - a study with labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol Scand 1972; 84: 306-19.
52. Josefsson A, Sigurdsson SB, Bang K, Eysteinsson T. Dorzolamide induces vasodilatation in isolated pre-contracted bovine retinal arteries. Exp Eye Res 2004; 78: 215-21.
53. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982; 94: 91-6.